


Welcome to the first homepage edition of i2P for 2012.
In many ways it has been a slow start to the New Year because of having to deal with the “leftovers” from 2011.
One of those items for i2P was that a third-party provider to the site did not advise of a code change to the security section in our subscribe panel, creating a range of frustrated subscribers not able to get on board.
We apologise to all those potential subscribers who were unable to register with us in the second half of 2011, but if you try once more you should have no problem.
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 2012 Number 1
![]() | Staff Writer |
Editing and Researching news and stories about global and local Pharmacy Issues | |
The effects of diabetes on organs such as the heart, eyes and kidneys are relatively well known, but women are now being warned of its potential to cause damage in another way – to sexual performance.
Victoria University’s Professor Lily Stojanovska and Dr Michael Mathai are conducting a study to assess the potential for improving sexual function in women with type 2 diabetes by taking a supplement from a plant traditionally used for this purpose in Peru.
The root of the plant Maca (Lepidium meyenii), which grows in the Peruvian Andes, has been used by locals for centuries, where it is reported to enhance fertility and to boost energy levels.
“We know from trials in our laboratory, and other published data that Maca improves sexual function in postmenopausal women,” Professor Stojanovska said.
“Now we want to conduct a trial on sexually active women with type 2 diabetes aged 30-49 to see how it works for them.”
Professor Stojanovska and her research colleague, Dr Michael Mathai, are recruiting women who fit this profile from the western suburbs of Melbourne.
“Participants will be randomly assigned a 3.25g daily dose of Maca or a placebo of rice flower for 8 weeks each, Professor Stojanovska said. Each participant will receive Maca and the placebo over the 16 weeks trial.
“We will measure plasma glucose and insulin at three points – before commencement, at 8 weeks and at 16 weeks of treatment. Participants will also be asked to complete questionnaires related to sexual satisfaction.
“We expect to find an improvement in sexual satisfaction and also in the indicators for diabetes.”
Women who fit the profile and who would like to participate in the study can contact Professor Stojanovska (9919 2737) or Dr Mathai (9919 2211) or research assistant Viki Kitanovska (0419 309 557 at the School of Biomedical and Health Sciences.
Return to home
Neil Retallick: Are the discounters impacting community pharmacy beyond margin erosion? | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Support services for pharmacists and doctors in the United Kingdom – Part 3 Royal Medical Benevolent Fund | open full screen
Staff Writer: Catch the early wave in 2012 and secure your valuable CPD Credits at the Guild Pharmacy Academy – NSW Convention | open full screen
If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.
Post new comment